{"title":"植物源性细胞外囊泡微核糖核酸谱的鉴定及其潜在的交叉皮调控","authors":"Fei Wang, Junyao Deng, Shushan Mo, Jiacong Ai, Yingxian Xiao, Xiaohan Zhou, Zhenhua Li, Lanya Li","doi":"10.1002/anbr.202400193","DOIUrl":null,"url":null,"abstract":"<p>Plant-derived extracellular vesicles (pEVs) are nanosized vesicles that have comparable structure and properties to EVs derived from mammalian cells. Prior studies have confirmed that pEVs have remarkable efficacy in the treatment of human diseases, such as cancer. As critical regulators of gene expression, microRNAs (miRNAs) are abundant in pEVs. However, their potential functional roles and regulatory mechanisms in mediating crosskingdom regulation of mammalian cells by pEVs remain undefined. In particular, the similarities and differences in the miRNA profiles of various pEVs in gene regulation remain elusive. Herein, pEVs are isolated from grapefruit, ginger, lemon, and grape, and small RNA (sRNA) libraries are constructed to perform sRNA sequencing. Only 15 consistently expressed miRNAs are identified in these pEVs. Furthermore, the top 20 miRNAs of each pEV are highly expressed among total miRNAs, accounting for 79.93–87.12%. Through functional annotation analysis of the miRNA target genes, these miRNAs are found to be involved in regulating the progression of human cancer and viral infection. Taken together, this study demonstrates that the miRNAs contained in the pEVs play a critical role in mediating the potential crosskingdom regulatory effects against human genes and highlights their significant potential therapeutic applications in human diseases.</p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"5 5","pages":""},"PeriodicalIF":4.0000,"publicationDate":"2025-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202400193","citationCount":"0","resultStr":"{\"title\":\"Identification of the Micro-Ribonucleic Acid Profiles of Plant-Derived Extracellular Vesicles and their Potential Crosskingdom Regulation\",\"authors\":\"Fei Wang, Junyao Deng, Shushan Mo, Jiacong Ai, Yingxian Xiao, Xiaohan Zhou, Zhenhua Li, Lanya Li\",\"doi\":\"10.1002/anbr.202400193\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Plant-derived extracellular vesicles (pEVs) are nanosized vesicles that have comparable structure and properties to EVs derived from mammalian cells. Prior studies have confirmed that pEVs have remarkable efficacy in the treatment of human diseases, such as cancer. As critical regulators of gene expression, microRNAs (miRNAs) are abundant in pEVs. However, their potential functional roles and regulatory mechanisms in mediating crosskingdom regulation of mammalian cells by pEVs remain undefined. In particular, the similarities and differences in the miRNA profiles of various pEVs in gene regulation remain elusive. Herein, pEVs are isolated from grapefruit, ginger, lemon, and grape, and small RNA (sRNA) libraries are constructed to perform sRNA sequencing. Only 15 consistently expressed miRNAs are identified in these pEVs. Furthermore, the top 20 miRNAs of each pEV are highly expressed among total miRNAs, accounting for 79.93–87.12%. Through functional annotation analysis of the miRNA target genes, these miRNAs are found to be involved in regulating the progression of human cancer and viral infection. Taken together, this study demonstrates that the miRNAs contained in the pEVs play a critical role in mediating the potential crosskingdom regulatory effects against human genes and highlights their significant potential therapeutic applications in human diseases.</p>\",\"PeriodicalId\":29975,\"journal\":{\"name\":\"Advanced Nanobiomed Research\",\"volume\":\"5 5\",\"pages\":\"\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-03-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202400193\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advanced Nanobiomed Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/anbr.202400193\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Nanobiomed Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/anbr.202400193","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
Identification of the Micro-Ribonucleic Acid Profiles of Plant-Derived Extracellular Vesicles and their Potential Crosskingdom Regulation
Plant-derived extracellular vesicles (pEVs) are nanosized vesicles that have comparable structure and properties to EVs derived from mammalian cells. Prior studies have confirmed that pEVs have remarkable efficacy in the treatment of human diseases, such as cancer. As critical regulators of gene expression, microRNAs (miRNAs) are abundant in pEVs. However, their potential functional roles and regulatory mechanisms in mediating crosskingdom regulation of mammalian cells by pEVs remain undefined. In particular, the similarities and differences in the miRNA profiles of various pEVs in gene regulation remain elusive. Herein, pEVs are isolated from grapefruit, ginger, lemon, and grape, and small RNA (sRNA) libraries are constructed to perform sRNA sequencing. Only 15 consistently expressed miRNAs are identified in these pEVs. Furthermore, the top 20 miRNAs of each pEV are highly expressed among total miRNAs, accounting for 79.93–87.12%. Through functional annotation analysis of the miRNA target genes, these miRNAs are found to be involved in regulating the progression of human cancer and viral infection. Taken together, this study demonstrates that the miRNAs contained in the pEVs play a critical role in mediating the potential crosskingdom regulatory effects against human genes and highlights their significant potential therapeutic applications in human diseases.
期刊介绍:
Advanced NanoBiomed Research will provide an Open Access home for cutting-edge nanomedicine, bioengineering and biomaterials research aimed at improving human health. The journal will capture a broad spectrum of research from increasingly multi- and interdisciplinary fields of the traditional areas of biomedicine, bioengineering and health-related materials science as well as precision and personalized medicine, drug delivery, and artificial intelligence-driven health science.
The scope of Advanced NanoBiomed Research will cover the following key subject areas:
▪ Nanomedicine and nanotechnology, with applications in drug and gene delivery, diagnostics, theranostics, photothermal and photodynamic therapy and multimodal imaging.
▪ Biomaterials, including hydrogels, 2D materials, biopolymers, composites, biodegradable materials, biohybrids and biomimetics (such as artificial cells, exosomes and extracellular vesicles), as well as all organic and inorganic materials for biomedical applications.
▪ Biointerfaces, such as anti-microbial surfaces and coatings, as well as interfaces for cellular engineering, immunoengineering and 3D cell culture.
▪ Biofabrication including (bio)inks and technologies, towards generation of functional tissues and organs.
▪ Tissue engineering and regenerative medicine, including scaffolds and scaffold-free approaches, for bone, ligament, muscle, skin, neural, cardiac tissue engineering and tissue vascularization.
▪ Devices for healthcare applications, disease modelling and treatment, such as diagnostics, lab-on-a-chip, organs-on-a-chip, bioMEMS, bioelectronics, wearables, actuators, soft robotics, and intelligent drug delivery systems.
with a strong focus on applications of these fields, from bench-to-bedside, for treatment of all diseases and disorders, such as infectious, autoimmune, cardiovascular and metabolic diseases, neurological disorders and cancer; including pharmacology and toxicology studies.